Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study

(1) Objective: Atomoxetine is a selective norepinephrine reuptake inhibitor used to treat attention-deficit/hyperactivity disorder (ADHD) in children over six years old. Although it is common knowledge that primary school children with ADHD often present with difficulties in the morning prior to sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Huiya, Xie, Ruijin, Li, Tianxiao, Chen, Zongxin, Liu, Yueying, Sun, Chenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870549/
https://www.ncbi.nlm.nih.gov/pubmed/35204932
http://dx.doi.org/10.3390/children9020212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870549/
https://www.ncbi.nlm.nih.gov/pubmed/35204932
http://dx.doi.org/10.3390/children9020212

Ejemplares similares